304 related articles for article (PubMed ID: 17415529)
21. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).
Han ZB; Ren H; Zhao H; Chi Y; Chen K; Zhou B; Liu YJ; Zhang L; Xu B; Liu B; Yang R; Han ZC
Carcinogenesis; 2008 Oct; 29(10):1853-61. PubMed ID: 18339685
[TBL] [Abstract][Full Text] [Related]
22. Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway.
Dayan F; Bilton RL; Laferrière J; Trottier E; Roux D; Pouyssegur J; Mazure NM
J Cell Physiol; 2009 Jan; 218(1):167-74. PubMed ID: 18781596
[TBL] [Abstract][Full Text] [Related]
23. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.
Knaup KX; Jozefowski K; Schmidt R; Bernhardt WM; Weidemann A; Juergensen JS; Warnecke C; Eckardt KU; Wiesener MS
Mol Cancer Res; 2009 Jan; 7(1):88-98. PubMed ID: 19147540
[TBL] [Abstract][Full Text] [Related]
24. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic cells in tumors as a target for cancer therapy.
Gali-Muhtasib HU; Diab-Assef M; Haddadin MJ
J Med Liban; 2002; 50(4):175-9. PubMed ID: 15298478
[TBL] [Abstract][Full Text] [Related]
26. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
Verheul HM; Salumbides B; Van Erp K; Hammers H; Qian DZ; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2008 Jun; 14(11):3589-97. PubMed ID: 18519793
[TBL] [Abstract][Full Text] [Related]
27. Prospective strategies to enforce selectively cell death in cancer cells.
Blagosklonny MV
Oncogene; 2004 Apr; 23(16):2967-75. PubMed ID: 15077157
[TBL] [Abstract][Full Text] [Related]
28. Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells.
Alqawi O; Wang HP; Espiritu M; Singh G
Free Radic Res; 2007 Jul; 41(7):788-97. PubMed ID: 17577739
[TBL] [Abstract][Full Text] [Related]
29. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia in head and neck cancer: how much, how important?
Janssen HL; Haustermans KM; Balm AJ; Begg AC
Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
[TBL] [Abstract][Full Text] [Related]
31. Effects of hypoxia on tumor metabolism.
Kim JW; Gao P; Dang CV
Cancer Metastasis Rev; 2007 Jun; 26(2):291-8. PubMed ID: 17415528
[TBL] [Abstract][Full Text] [Related]
32. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
33. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments.
Martinive P; Defresne F; Quaghebeur E; Daneau G; Crokart N; Grégoire V; Gallez B; Dessy C; Feron O
FEBS J; 2009 Jan; 276(2):509-18. PubMed ID: 19077164
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia signalling through mTOR and the unfolded protein response in cancer.
Wouters BG; Koritzinsky M
Nat Rev Cancer; 2008 Nov; 8(11):851-64. PubMed ID: 18846101
[TBL] [Abstract][Full Text] [Related]
35. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.
Skuli N; Monferran S; Delmas C; Favre G; Bonnet J; Toulas C; Cohen-Jonathan Moyal E
Cancer Res; 2009 Apr; 69(8):3308-16. PubMed ID: 19351861
[TBL] [Abstract][Full Text] [Related]
36. Dual role of HIF-1alpha in delivering a survival or death signal in hypoxia exposed human K562 erythroleukemia cells.
di Giacomo V; Rapino M; Miscia S; Di Giulio C; Cataldi A
Cell Biol Int; 2009 Jan; 33(1):49-56. PubMed ID: 18996491
[TBL] [Abstract][Full Text] [Related]
37. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.
Choi KJ; Piao YJ; Lim MJ; Kim JH; Ha J; Choe W; Kim SS
Cancer Res; 2007 Apr; 67(8):3654-62. PubMed ID: 17440077
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia targeting gene expression for breast cancer gene therapy.
Lee M
Adv Drug Deliv Rev; 2009 Aug; 61(10):842-9. PubMed ID: 19426773
[TBL] [Abstract][Full Text] [Related]
39. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
Chen C; Yu Z
Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
[TBL] [Abstract][Full Text] [Related]
40. Hammerhead ribozyme targeting human hypoxia inducible factor-1alpha gene effectively attenuates HeLa xenograft tumors.
Yu R; Chen R; Shi Q; Li T; Tang H
Surg Neurol; 2009 Aug; 72 Suppl 1():S8-S16; discussion S16. PubMed ID: 18514274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
